Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations —going beyond the body‐size effect

This study approach may be applicable to the optimization of pediatric dosing o f other mAbs and possibly other biologics.

Source: CPT: Pharmacometrics and Systems Pharmacology - December 20, 2023 Category: Drugs & Pharmacology Authors: Zheyi Hu, Sihang Liu, Yue Zhao, Shengnan Du, Lora Hamuro, Jun Shen, Amit Roy, Li Zhu Tags: ARTICLE Source Type: research